A promising class of compounds for DNA transfection have been designed by conjugating various potyamines to bile-acid-based amphiphiles. Formulations containing these compounds were tested for their ability to facilitate the uptake of a 3-galactosidase reporter plasmid into COS-7 cells. Dioleoyl phosphatidyl ethanolamine (DOPE) formulations of some of the compounds were several times better than Lipofectin at promoting DNA uptake. The most active compounds contained the most hydrophilic bile acid components.
Gene therapy is an exciting approach to the treatment of genetic defects, as well as diseases such as cancer and chronic viral infections (1) (2) (3) . Unfortunately, the enthusiasm initially displayed for gene therapy has been tempered by the realization that there are no easy solutions to the problem of how to get genes into cells. The most efficient methods for transferring DNA across cell membranes involve the use of viral vectors (1, 4, 5) ; however, there are growing concerns about both the short-and long-term risks ofviral vectors. These concerns have prompted a search for other strategies for DNA delivery, and in the past few years, a variety of nonviral gene delivery systems have been investigated (6) (7) (8) (9) . Although some success in getting DNA into cells has been achieved, gene delivery with nonviral vectors remains an inefficient process. To make gene therapy a reality, more efficient DNA delivery systems are needed. In this paper, we report the design and preliminary evaluation of a promising class of DNA delivery agents.
In designing these delivery agents, we started by considering the properties of existing nonviral delivery systems. Of all the nonviral DNA delivery systems that have been explored, cationic lipids have shown the most promise based on a combination of efficacy, stability, and toxicity. Lipofectin ( Fig.  1 ), a 1:1 mixture of the cationic lipid N-[1,2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA) and the fusogenic lipid dioleoyl phosphatidylethanolamine (DOPE), was the first cationic lipid formulation to receive widespread attention as a gene delivery agent (10) . Since its introduction in 1987, many other cationic lipid formulations have been tested (11) (12) (13) (14) (15) . The mechanism by which cationic lipid formulations promote DNA uptake is not well understood, but a model for how they function is beginning to emerge from the experimental data (6, 16) . It 
is believed that cationic lipids
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. interact with the negatively charged phosphate backbone of DNA, neutralizing the charge and promoting collapse of the DNA into a more compact structure. Because the resulting DNA-cationic lipid particles have a net positive charge, they interact with negatively charged biological membranes. What happens next is unclear, but somehow the DNA-lipid particle enters the cell. Entry may occur directly through the plasma membrane or via an intermediate endosome (12, 15, 16) . Because many cationic delivery formulations require the presence of a phosphatidylethanolamine capable of destabilizing bilayer membranes and promoting membrane fusion (e.g., DOPE; Fig. 1 ), it is believed that the DNA-lipid particle must fuse with and/or destabilize the plasma membrane or the endosomal membrane to enter the cytoplasm.
Because there is no clear understanding of what happens to functionally active transfecting particles at the membrane surface, it is difficult to design better chemical delivery agents. Although a cationic component is necessary in any effective gene delivery agent, there is no prescription for what other structural features should be included in such a molecule. It has generally been assumed that the cationic component should be attached to a nonpolar tail, and double-and single-chain lipids as well as cholesterol have been used as nonpolar tails (16) . The double-chain lipids have shown the greatest efficacy. Nevertheless, recent evidence suggests that other structural motifs may work as well or better.
For example, Legendre and Szoka (17) have found that a mixture of DOPE and a cationic amphiphilic peptide known to permeabilize membranes facilitates uptake of DNA into some cell types better than Lipofectin. Amphiphilic peptides are unusual -as amphiphiles because the hydrophilic and hydrophobic regions are segregated along the long axis of the molecules (Fig. 2a) . This facially amphiphilic arrangement influences the way in which amphiphilic peptides interact with membranes and is partly responsible for their ability to permeabilize membranes at low concentrations and promote membrane fusion (18 acid (one hydroxyl), chenodeoxycholic acid (two hydroxyls), and cholic acid (three hydroxyls), as well as one unnatural skeleton, 7,12-a,a-bisglucosyl cholic acid, which was synthesized recently as an enhanced facial amphiphile (Fig. 2b) (20 (21) . Lipofectin was purchased from GIBCO/BRL. Cholic acid, chenodeoxycholic acid, and lithocholic acid were purchased from Aldrich and esterified with methanolic HCl.
Ten compounds were synthesized for this report by coupling the appropriate polyamine to bile acid derivatives la-4a (Fig.  3) . The synthesis of the benzyl-protected 7,12-bisglycosylated cholic acid derivative 4a from the cholic acid methyl ester has been reported (20, 22) . The methyl esters la-4a were converted to the corresponding N-hydroxysuccinimide esters or the acylazides and then treated with the desired polyamine (spermine, tetraethylenepentamine, or pentaethylenehexamine) as shown in Fig. 3 . Subsequent to polyamine conjugation, the 7,12-bistetra-O-benzylglucosyl cholic acid derivatives were debenzylated with Pd(OH)2/C in the presence of H2(g) to provide analogs 4b, 4c, and 4d. All final products were purified by passage over CHP-20P reverse-phase column chromatography and were fully characterized by 1H (23) . The ,B-galactosidase activity of Lipofectin-treated cells under optimal conditions was evaluated in parallel, and the transfection activity at the optimal concentration of each cationic lipid formulation is reported as a percentage of the Lipofectin control. Transfection frequency was determined by counting cells stained in situ
In some experiments, chloroquine was added to a final concentration of 100 ,uM during the transfection. The toxicity of the lipid formulations was evaluated by comparing the amount of MTT reduced by control COS-7 cells to the amount reduced by COS-7 cells treated with the cationic bile acid formulations (24) . IC50 values are the concentration of compound that produces 50% cell viability.
Evaluation of Binding Affinity. The relative affinities of the various compounds for DNA were assessed by using an ethidium displacement assay (25) . The C50 value is the concentration of cationic bile acid that gives a 50% reduction in the fluorescence intensity of a solution containing doublestranded calf thymus DNA (1.32 ,uM in base pairs) and ethidium bromide (1.26 ,uM) in 10 mM SHE buffer (8 mM NaCl/2 mM Hepes/0.05 mM EDTA, pH 7.0).
The ability of the cationic compounds to form complexes with DNA in the presence and absence of DOPE was also assessed with a gel retardation assay. Plasmid DNA (0.25 j,g) was briefly incubated with various concentrations of each compound or formulation in SHE buffer and then electrophoresed at 100 V in TBE buffer on a 0.9% agarose gel containing ethidium bromide at 5 ,ug/ml.
Measurement of Transfecting Particle Sizes. Lipid formulations were prepared as described above and added to plasmid DNA in 100 ,ul of phosphate-buffered saline at the optimal molar ratio for transfection. The mixtures were vortex mixed and allowed to stand for 15 min at room temperature before dilution with phosphate-buffered saline to a final volume of 3 ml. The hydrodynamic radii of the complexes were determined by dynamic light scattering experiments with a laser light scattering goniometer and BI-2030AT digital correlator (Brookhaven Instruments, Holtsville, NY). Measurements were taken at 25.5°C by using a wavelength of 514.5 nm and an angle of 90°.
RESULTS AND DISCUSSION
Description of the Compounds. We investigated a range of bile acid derivatives, from the very nonpolar lithocholic acid derivative 3a to the polar bisglycosylated derivative 4a as components of the gene delivery agents. Lithocholic acid is not a true facial amphiphile because it contains only a single hydroxyl located at one end of the steroid nucleus. The bisglycosylated derivative was designed to have enhanced facial amphiphilicity relative to the natural bile acids (20) . The different bile acids were tailored to interact with DNA by attaching various polyamines to the acid side chain to make the corresponding amides (Fig. 3) . The side chain is both the simplest position to derivatize and the least likely to affect the amphiphilic properties of the bile acid core. The polyamines investigated were spermine, tetraethylenepentamine, and pentaethylenehexamine. The amines in spermine are protonated in water at pH 7.0, and we have assumed a charge of +3 for the spermine conjugates. The reported pKa values for the amines in triethylenetetramine are 10.0, 9.3, 6.9, and 3.7 (26, 27) . The bile acid conjugates of tetraethylenepentamine contain a triethylenetetramine unit and we have assumed a charge of +2.5 for these compounds. The pKa values of tetraethylenepentamine are 10.0, 9.2, 8.2, 4.1, and 2.6, and we have assumed a charge of +3 for the bile acid conjugates of pentaethylenehexamine (26, 27) .
Transfection Results. Formulations of each cationic facial amphiphile and DOPE were prepared as described above. Their ability to promote the uptake of a ,B-galactosidase reporter plasmid was evaluated by measuring the ,B-galactosidase activity in lysates of transfected cells. (17) . Our hydrophilic bile acid conjugates contain steroids that are facially amphiphilic like amphiphilic peptides. In fact, the bisglycosylated steroid 4a was specifically designed as an amphiphilic peptide mimic (20) . Our results show that nonpeptidic facial amphiphiles can promote DNA uptake like peptidic facial amphiphiles. Nonpeptidic facial amphiphiles have clear advantages over peptidic facial amphiphiles in terms of both expense and chemical stability. Moreover, our cationic facial amphiphiles have much lower toxicity than many membrane-active peptides (17) . A standard MTT toxicity assay shows that the IC50 values for DOPE formulations of the best compounds (1c, ld, and 4d) range from 0.1 to 0.3 mM, much higher than the concentrations used in transfection. For comparison, the toxicity of Lipofectin in this assay is 0.2 mM.
Finally, we point out that very high transfection activities were achieved with some of the polyethylenediamine conjugates, particularly the hexamine conjugates. Spermine, a biogenic polyamine known to bind to DNA, has been used in the design of several other cationic lipids (14, 16) . Polyethylenediamine chains have not been used in synthetic transfection agents (28) and yet our results show that they function better than the spermine side chain in a number of cases even though they have a lower intrinsic affinity for DNA (see below).
Further studies will be necessary to establish whether the increased activity is related to different spacing between charged amines, to the presence of additional amines that can be protonated in the endosome (see below), or to other factors; however, it is evident from this work that there is still much to be learned about the optimum cationic head group structure.
The Role of the Lipid. Many cationic transfection formulations require a neutral phospholipid for optimal activity (12, 13, 15, 17, 29) . The neutral phospholipid is usually a phosphatidylethanolamine analogue such as DOPE. DOPE forms unstable bilayers and may enhance transfection activity because it facilitates fusion of the DNA-lipid complex with the plasma membrane or the endosomal membrane (30) . Lipids that form bilayers that are refractory to fusion (e.g., DOPC) generally inhibit transfection activity.
We examined the requirement for a neutral phospholipid in our formulations by carrying out transfections with some of the best bile acid-polyamine conjugates in the presence and absence of both DOPE and DOPC. None Effect of Chloroquine on Transfection Activity. Cationic transfection complexes can enter the cytoplasm by direct fusion with the plasma membrane or by endocytosis followed by release of the DNA from the endocytic vesicle (16, 17, 29) . Some complexes appear to be taken up efficiently by endocytosis, but they are unable to escape from the endosome before it fuses with the lysosomal compartment where macromolecular degradation occurs. Chloroquine is a weak base that inhibits fusion of the endosome with the lysosome by buffering the lysosome interior (13, 15, 29) . Because complexes have more time to escape from the endosome, chloroquine often increases transfection activity. We included chloroquine during transfections with lc, ld, and 4d but saw no significant increase in f3-galactosidase activity. In contrast, chloroquine improved the activity of Lipofectin-DNA complexes by a factor of 2.5. We have concluded that if any of our complexes enter cells by an endosomal route, they are able to escape more efficiently than Lipofectin complexes. It has been suggested that transfection agents containing amines that can be protonated buffer the endosome and facilitate escape into the cytoplasm (28) .
Particle Size. The complexes formed between the cationic bile acid formulations and DNA were measured by dynamic light scattering. The most active transfection formulations (i.e., lc, ld, and 4d) formed complexes approximately 1 ,tm in diameter at the optimal molar ratios used for transfection. The corresponding DOPC complexes, which were found to be inactive in the transfection assay, formed significantly smaller complexes (-0.7 ,um). The least active cationic bile acids formed relatively small complexes even with DOPE (e.g., <0.4 Am for both 2c and 3d).
Affinity for DNA. We have evaluated the relative affinities of the different cationic bile acids for DNA to determine whether transfection efficiency correlates with DNA binding. Relative affinities were assessed with two assays, an ethidium displacement assay and a gel retardation assay (Fig. 4) . The ethidium displacement assay has been used previously to evaluate the relative DNA binding affinities of various polyamines (26, 29, 31) as well as some other bile acid-polyamine conjugates (25) . This assay shows that the C50 values for most of our cationic bile acid compounds fall within a narrow range, between approximately 1 and 5 ,uM (Fig. 4a) . One notable exception is compound 4c, with a C50 value of 40 ,uM. Compound 4c is comparable to Lipofectin in its ability to transfect COS-7 cells. The closely related hexamine conjugate 4d binds about 10 times more tightly to DNA and is about 10 times more active. This comparison would seem to suggest that binding affinity and transfection activity are correlated. However, several compounds that have relatively high affinities for DNA according to the ethidium displacement assay do not show significant activity (e.g., 2c and 2d).
The gel retardation assay has been used by others to monitor formation of complexes between DNA and various agents used for transfecting cells (17) . With a few exceptions, we found the results of the gel retardation assay to be consistent with the results of the ethidium displacement assay (Fig. 4) (Fig. 4b) ; the other conjugates can be fully retarded at higher charge ratios (data not shown). Hence, the polyamines themselves do not form stable complexes with DNA but the conjugates do. These results suggest that the bile acid portions of the conjugates interact favorably with one another and help to stabilize the complexes with DNA. The stabilizing interactions are not reflected in significantly decreased C50 values for the conjugates relative to the polyamines, but perhaps this is because the bile acids do not play a direct role in displacing ethidium (e.g., by contacting the DNA).
The binding assays indicate that the ability to form a stable complex with DNA is necessary for good transfection activity. The compounds that do not form stable complexes with DNA cannot facilitate transfection (see, e.g., the polyamines themselves). In some cases, it is possible to improve transfection activity by improving complex stability (compare 4c and 4d). However, the ability to form a stable complex with DNA is clearly not sufficient for high transfection activity. For example, the more hydrophobic bile acid conjugates form stable complexes with DNA at lower charge ratios than the hydrophilic bile acid conjugates (presumably because of favorable hydrophobic interactions between the steroids), and yet they tend to be far less active in transfection (compare, for example, the gel retardation and transfection results of 2c and 2d to 4c and 4d). The reason for the increased activity of the DNA complexes formed by the hydrophilic conjugates is not clear; however, the structural differences between the hydrophobic and hydrophilic bile acid conjugates influence the size of the transfecting particles that form with DNA (see above) and undoubtedly affect how the particles interact with membranes. We speculate that the active transfecting particles have an increased ability to fuse with membranes.
CONCLUSION
We have designed a class of transfection agents that function better than a commercially available cationic lipid for transfecting a standard cultured cell line. These transfection agents are very different from standard cationic lipids. On first view they might appear to resemble the cationic cholesterol transfection agents that have been tested because they contain both a steroidal portion and an amine chain (16, 29) . However, the cholesterol-based transfection agents contain a nonpolar steroid tail whereas our best compounds contain a highly polar steroid tail. There is no precedence in the cationic lipid literature that increasing the polarity of the tail would improve transfection efficiency. In fact, the best precedence that these kinds of compounds might work comes from the studies of Legendre and Szoka (17) , who showed that some amphiphilic peptides promote DNA uptake. Although a cursory look would suggest that there are no structural similarities between amphiphilic peptides and polyhydroxylated bile acid derivatives, further consideration reveals that both types of molecules have the unusual distribution of hydrophilic and hydrophobic domains that we call facial amphiphilicity (Fig. 2) . Facially amphiphilic molecules have interesting physicochemical properties (20, 32) . Some facially amphiphilic peptides are known to permeabilize membranes and promote membrane fusion (17) . The bile acids and some of their glycosylated derivatives are also known to permeabilize membranes (19, 33) . Because functionally active transfecting particles must penetrate cell membranes-and because Szoka (17) had shown that membrane-destabilizing amphiphilic peptides could facilitate DNA uptake-we thought that amphiphilic bile acid derivatives might make better components of gene delivery vehicles than the hydrocarbon chains used in synthetic cationic lipids.
The results reported above support the idea that incorporating facial amphiphiles into synthetic DNA delivery agents can lead to high transfection levels. The most active compounds tested have the highest degree of facial amphiphilicity. In fact, the best compound contains a glycosylated bile acid derivative that was originally designed as a minimalist analogue of a facially amphiphilic peptide (20) . The differences in activity between the different cationic bile acid derivatives are clearly not related to differences in the stability of the resulting DNA complexes: the more hydrophobic compounds have a higher affinity for DNA and form stable complexes at lower charge ratios. We designed the compounds based on the idea that facially amphiphilic components known to destabilize membranes (19, 33) 
